Oxford and GSK launch £50m programme to advance cancer research
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
Read moreLatest News
Sounds of Tolerance
4 June 2026
Upcoming Talks
23rd Hot Topics in Infection and Immunity in Children (IIC) – the ESPID-Oxford Course
Tuesday, 23 June 2026 to Thursday, 25 June 2026, 10am - 2pm
Dominant effects of loss- and gain-of-function variants in neuronal endosomal CLC transporters
Tuesday, 23 June 2026, 12pm to 1pm
Lunchtime Lab Talks: Mentzer & Beagrie Groups
Wednesday, 24 June 2026, 12.30pm to 1.30pm
Status: Cancelled
Barrier immune niches during microbial colonization and infection
Wednesday, 24 June 2026, 2pm to 3pm
Latest publications
The double-edged nature of antibody bivalency: mathematical and experimental analysis of cell surface antigen occupancy and opsonization.
Journal article
Heirene L. et al, (2026), MAbs, 18
DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models.
Journal article
Morgado-Cáceres P. et al, (2026), Oncoimmunology, 15
Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization.
Journal article
van Niekerk L. et al, (2026), MAbs, 18
Systematic review and data-driven insights into CHO cell engineering for next-generation antibody production.
Journal article
Schulz A. et al, (2026), MAbs, 18